In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Quincy Bioscience LLC

This article was originally published in Start Up

Executive Summary

Insights into calcium's role in neurodegeneration is encouraging research into the role it plays in Alzheimer's and other diseases, and in the aging process in general. Much of the work has revolved around the concept of blocking calcium channels, but Quincy Bioscience thinks it has a better approach. Its compound has been utilized in laboratories for 40-some years, but not as a potential drug. It's aeqorin, a luminescent protein originally isolated from jellyfish.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC091272

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel